Guillou C - Search Results

1

Further investigation of Paprotrain: Towards the conception of selective and multi-targeted CNS kinase inhibitors.

Labrière C, Lozach O, Blairvacq M, Meijer L, Guillou C. Labrière C, et al. Among authors: guillou c. Eur J Med Chem. 2016 Nov 29;124:920-934. doi: 10.1016/j.ejmech.2016.08.069. Epub 2016 Aug 31. Eur J Med Chem. 2016. PMID: 27676471

2

New potent acetylcholinesterase inhibitors in the tetracyclic triterpene series.

Sauvaître T, Barlier M, Herlem D, Gresh N, Chiaroni A, Guenard D, Guillou C. Sauvaître T, et al. Among authors: guillou c. J Med Chem. 2007 Nov 1;50(22):5311-23. doi: 10.1021/jm070536w. Epub 2007 Sep 29. J Med Chem. 2007. PMID: 17902635

3

Relocation of Aurora B and survivin from centromeres to the central spindle impaired by a kinesin-specific MKLP-2 inhibitor.

Tcherniuk S, Skoufias DA, Labriere C, Rath O, Gueritte F, Guillou C, Kozielski F. Tcherniuk S, et al. Among authors: guillou c. Angew Chem Int Ed Engl. 2010 Oct 25;49(44):8228-31. doi: 10.1002/anie.201003254. Angew Chem Int Ed Engl. 2010. PMID: 20857469 No abstract available.

4

New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.

Rouleau J, Iorga BI, Guillou C. Rouleau J, et al. Among authors: guillou c. Eur J Med Chem. 2011 Jun;46(6):2193-205. doi: 10.1016/j.ejmech.2011.02.073. Epub 2011 Mar 23. Eur J Med Chem. 2011. PMID: 21435752 Free article.

5

New MKLP-2 inhibitors in the paprotrain series: Design, synthesis and biological evaluations.

Labrière C, Talapatra SK, Thoret S, Bougeret C, Kozielski F, Guillou C. Labrière C, et al. Among authors: guillou c. Bioorg Med Chem. 2016 Feb 15;24(4):721-34. doi: 10.1016/j.bmc.2015.12.042. Epub 2015 Dec 24. Bioorg Med Chem. 2016. PMID: 26778612

6

Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series.

Mary A, Renko DZ, Guillou C, Thal C. Mary A, et al. Among authors: guillou c. Bioorg Med Chem. 1998 Oct;6(10):1835-50. doi: 10.1016/s0968-0896(98)00133-3. Bioorg Med Chem. 1998. PMID: 9839013

7

Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts.

Guillou C, Mary A, Renko DZ, Gras E, Thal C. Guillou C, et al. Bioorg Med Chem Lett. 2000 Apr 3;10(7):637-9. doi: 10.1016/s0960-894x(00)00059-7. Bioorg Med Chem Lett. 2000. PMID: 10762042

8

Synthesis and structure-activity relationships of open D-Ring galanthamine analogues.

Herlem D, Martin MT, Thal C, Guillou C. Herlem D, et al. Among authors: guillou c. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2389-91. doi: 10.1016/s0960-894x(03)00397-4. Bioorg Med Chem Lett. 2003. PMID: 12824041

9

Discovery of two new inhibitors of Botrytis cinerea chitin synthase by a chemical library screening.

Magellan H, Boccara M, Drujon T, Soulié MC, Guillou C, Dubois J, Becker HF. Magellan H, et al. Among authors: guillou c. Bioorg Med Chem. 2013 Sep 1;21(17):4997-5003. doi: 10.1016/j.bmc.2013.06.058. Epub 2013 Jul 2. Bioorg Med Chem. 2013. PMID: 23886809

10

Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.

Pérez-Areales FJ, Di Pietro O, Espargaró A, Vallverdú-Queralt A, Galdeano C, Ragusa IM, Viayna E, Guillou C, Clos MV, Pérez B, Sabaté R, Lamuela-Raventós RM, Luque FJ, Muñoz-Torrero D. Pérez-Areales FJ, et al. Among authors: guillou c. Bioorg Med Chem. 2014 Oct 1;22(19):5298-307. doi: 10.1016/j.bmc.2014.07.053. Epub 2014 Aug 7. Bioorg Med Chem. 2014. PMID: 25156301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page